UNSPSC 51241705: Benzalkonium chloride/hydroxypropyl methylcellulose/polyvinyl alcohol

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OP400. This VA Drug Class (OP400) classifies this compound as belonging to the group CONTACT LENS SOLUTIONS.

UNSPSC 51241705 Benzalkonium chloride/hydroxypropyl methylcellulose/polyvinyl alcohol is a Commodity code covering pharmaceutical and over-the-counter (OTC) ophthalmic and topical products—specifically solutions and compounds combining active ingredients for eye care, wound care, and similar therapeutic applications. State and local government procurement under this code focuses on acquiring finished pharmaceutical products through cooperative purchasing agreements that consolidate demand across multiple jurisdictions and facilities. The issuing body for the most recent major opportunity is the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, which structures awards to serve participating state and local government facilities across multiple states including Oregon. MMCAP's model relies on manufacturers establishing relationships with authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) to distribute awarded products, ensuring that pricing and product availability decisions flow through established pharmaceutical supply chains rather than direct government procurement.

MMCAP issued an RFP (S1070000015802) on January 20, 2026, with a proposal deadline of March 26, 2026, to establish multi-award contracts for generic pharmaceuticals and OTC products effective July 1, 2026. Vendors must certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain contractual relationships with at least two of the three authorized wholesalers with chargeback systems in place, and provide comprehensive product data including National Drug Codes (NDC), SKUs, UPCs, strength, dosage form, and manufacturing location. Evaluation is weighted heavily toward price competitiveness (75 percent), with secondary weight on fixed pricing (10 percent), compliance with administrative data requirements (5 percent), EDI capability (5 percent), and acceptance of a 3 percent administrative fee (5 percent). Contract terms run two years for new vendors, with optional extensions at MMCAP's discretion; incumbent vendors' amendments align with existing expiration dates through June 30, 2028. All products must comply with FDA requirements, possess expiration dates at least one year from manufacture, and maintain a minimum six-month shelf life at distribution.